- About 90,000 women globally die from endometrial cancer each year1
- VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI (dostarlimab-gxly)
- Roche/GSK collaboration represents an important step towards a personalised healthcare strategy that can help identify patients who are most likely to benefit from a specific therapy
Category Archives: AZBio News
C-Path Opens Access to Duchenne Regulatory Science Consortium Database
Database will allow sharing of individual-level data with the goal of accelerating therapy development for Duchenne muscular dystrophy
TUCSON, Ariz., April 22, 2021 — Critical Path Institute (C-Path) announced today that it will open access to the Duchenne Regulatory Science Consortium (D-RSC) database to qualified researchers, through its Rare Disease Cures Accelerator, Data and Analytics Platform (RDCA-DAP®). The D-RSC database includes data from Duchenne muscular dystrophy (DMD) clinical trials, natural history studies and clinical data collections. The contributors of these datasets have given permission for this data to be shared externally to accelerate therapy development for DMD.
Flinn Foundation selects 20 excelling Arizona students as 2021 Flinn Scholars
Twenty of Arizona’s highest-achieving high-school seniors have been awarded the prestigious Flinn Scholarship and will receive a full ride at one of the state’s public universities.
Now in its 36th year, the Flinn Scholars Program is supported by the Phoenix-based Flinn Foundation in partnership with Arizona’s three state universities. The merit-based scholarship covers the full cost of tuition, mandatory fees, housing, meals, study abroad, and many other exclusive opportunities—a package valued at more than $120,000.
Just Announced: Additional SME COVID-19 Relief
As the country moves into a new phase of the vaccination effort – one where all adults are eligible for vaccinations – we want to ensure that you are aware of a new tax credit that President Biden announced today. The new paid leave tax credit will offset the cost for employers with fewer than 500 employees to provide full pay for when their employees get a COVID-19 vaccination or recover from that vaccination.
Johnson & Johnson Single-Shot COVID-19 Vaccine Phase 3 Data Published in New England Journal of Medicine
- Single-dose vaccine prevented hospitalization and death across all study participants, 28 days after vaccination
- Vaccine shown to be effective against severe/critical COVID-19 disease as early as seven days after vaccination, with efficacy continuing to increase eight weeks post-vaccination
- Vaccine also shown to be consistently effective against symptomatic infection, including in South Africa and Brazil where there was a high prevalence of rapidly emerging SARS-CoV-2 variants
Mayo study finds colon cancer driven by hereditary gene mutations in 1 in 6 patients
ROCHESTER, Minn. — A new Mayo Clinic study bolsters evidence that colorectal cancer is often imprinted in family genes and passed on from one generation to the next.
In the study, published in Clinical Gastroenterology and Hepatology, researchers within the Mayo Clinic Center for Individualized Medicine found 1 in 6 patients with colorectal cancer had an inherited cancer-related gene mutation, which likely predisposed them to the disease. In addition, the researchers discovered that 60% of these cases would not have been detected if relying on a standard guideline-based approach.
Biodesign Professor Dr. Alexandra Lucas Wins Third Annual ASU Faculty Startup Challenge
Serpass Biologics, Dr. Lucas’ startup, is developing a new class of immune-modulating biologics for autoimmune disorders. These can be used to treat and suppress excessive immune system responses in a wide range of diseases, including arthritic, cardiac, gastrointestinal, pulmonary and vascular disorders.
The annual competition is run by Skysong Innovations, which works across the university to help researchers pursue commercial applications for their work.
Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope
Talented team and industry-leading lab will help strengthen the company’s sequencing and pipeline capabilities, while broadening its therapy selection and treatment guidance offerings.
BD Announces 510(k) Clearance of Pristine™ Long-Term Hemodialysis Catheter
Clearance supported by clinical data from a feasibility study with favorable primary patency rates observed out to 180 days Pristine™ Long-Term Hemodialysis Catheter
Fruit Flies and Cellular Demise – Zeroing in on the Causes of ALS
New UArizona research has identified a previously unknown pattern of protein creation in the motor neurons, which are the cells that malfunction in patients with ALS. By restoring the missing proteins at one end of the cell, movement returns. Next, the team hopes to determine if the surprising over-production at the other end of the cell also has consequences.